Checkmate Capital Group LLC — Full Portfolio
18 tracked investments · listed companies and verified rows first
BiotechMalvern, US
Antony Koblish(Executive Officer, Director)inFrancis Conway(Executive Officer)Maarten Persenaire(Executive Officer)Christine Arasin(Executive Officer)
BoardKevin Rakin(Director)Ashley Freidman(Director)
Co-investorsEssex Woodlands Healthcare PartnersOrbiMedSignet Healthcare Partners1315 Capital
Austrianova is a biotech company that manufactures cell-based products using encapsulation technology and GMP-grade processes.
BiotechDeep TechHealthtechLongevityMedical DevicesSingapore, SG
Dr. Brian Salmons(CEO & President)Prof. Walter H. Günzburg(Chairman & CTO)
Co-investorsUntroD Capital
Altis Biosystems builds RepliGut®, human intestinal tissue models grown from human intestinal stem cells that provide human-relevant preclinical data for drug absorption, metabolism, toxicity, and disease modeling.
BiotechDeep TechHealthtechMedical DevicesDurham, US
Christopher Sims(Executive Officer)Jimmy Smedley(Executive Officer)inSamuel Franklin(Director)Joseph McMahon(Director)Michael Biron(Executive Officer, Director)
BoardChristopher Perkins(Director)
Co-investorsAtlanta Technology AngelsCentral Texas Angel NetworkIDEA NCJohnson Venture PartnersVentureSouthHatteras Venture Partners
CropX develops digital farming solutions for growers and agribusinesses to optimize agronomic decisions through soil sensors, precision irrigation, and data analytics.
AgTechAI & Machine LearningIoT
Tomer Tzachin
Co-investorsArmada Investment AGBosch VenturesGermin8 VenturesNZ Growth Capital PartnersPacific ChannelPresidio Ventures+3 more
Organics by Gosh is a regional composting company based in Austin, Texas that processes yard trimmings and food waste from residential and commercial sources, producing high-quality compost and blended soils for landscapers and contractors.
AgTechCircular EconomyCleantechClimate TechImpact & Social GoodAustin, US
MAIA Biotech is a clinical-stage biopharmaceutical company developing telomere-targeting cancer therapies, with a lead compound (THIO) based on a telomerase-targeting therapeutic approach.
BiotechHealthtechChicago, US
Sergei M. Gryaznov(Chief Scientific Officer)Jeffrey C. Himmelreich(Head of Finance)Vlad Vitoc(Chief Executive Officer and Chairman)Ngar Yee Louie(Director)
BoardCristian Luput(Director)Jean-Manasse Theagene(Director)
Monarch Biosciences develops and commercializes medical device and biotechnology products based on Thin Film Nitinol technology.
BiotechMedical DevicesNew Materials
NeuroSigma is a bioelectronic medical device company that makes non-invasive external trigeminal-nerve stimulation systems to treat chronic neurological and neuropsychiatric disorders.
Digital HealthHealthtechMedical DevicesLos Angeles, US
Leon Ekchian(Executive Officer, Director)Lodwrick M. Cook(Director)
BoardKirk Calhoun(Director)James Hindman(Director)
Precision Livestock provides a machine vision camera system that monitors cattle feed bunks and feeding behavior around the clock, converting the data into graphs, charts and alerts.
AgTechAI & Machine LearningIoT
Co-investorsNextFab Ventures
HealthtechTucson, US
Laurence John Marsteller(Executive Officer, Director)Harry Allan George(Executive Officer, Director)
Sana Health develops an audiovisual device intended to help users improve physical recovery and mental well-being, targeting relief and more restful states of mind.
Digital HealthHealthtechMedical DevicesMental HealthLafayette, US
Richard Hanbury(Founder)
Co-investorsClick VenturesFlucas VenturesHealthtech CapitalMonozukuri VenturesNCL Technology Ventures Ltd.Noetic+2 more
Triumvira is a clinical-stage immuno-oncology company developing autologous and allogeneic T cell therapeutics for cancer treatment.
BiotechHealthtechMedical DevicesAustin, US
TERESA MCROBERTS(Executive Officer)inPAUL LAMMERS, MD, MSc(Executive Officer, Director)inJON IRVIN(Executive Officer)in
BoardDANIEL JANSE(Director)JURGEN ECKHARDT(Director)ELIZABETH WILLIAMS(Director)
Co-investorsB Capital GroupB4 Capital
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.


